CompletedPhase 2NCT01894958
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Studying Fragile X syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Neuren Pharmaceuticals Limited
- Principal Investigator
- Elizabeth M Berry-Kravis, MDRush University Medical Center
- Intervention
- NNZ-2566(drug)
- Enrollment
- 72 enrolled
- Eligibility
- 12-45 years · MALE
- Timeline
- 2014 – 2015
Study locations (17)
- UC Davis MIND Institute, Sacramento, California, United States
- Children's Hospital Colorado, Denver, Colorado, United States
- Children's National Hospital, Washington D.C., District of Columbia, United States
- Emory University, Atlanta, Georgia, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- University of Massachusetts Medical School, Worcester, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- University of Nebraska, Omaha, Nebraska, United States
- Mount Sinai School of Medicine, New York, New York, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Autism & Developmental Medicine Institute Geisinger Health System, Lewisburg, Pennsylvania, United States
- Suburban Research Associates, Media, Pennsylvania, United States
- Greenwood Genetic Center, Greenwood, South Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01894958 on ClinicalTrials.govOther trials for Fragile X syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07493096Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal DisordersHealing Hope International
- RECRUITINGPHASE2NCT07209462Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)Mirum Pharmaceuticals, Inc.
- RECRUITINGNANCT06868979Optical Imaging in X-linked Disorders.Hospices Civils de Lyon
- RECRUITINGNANCT06740162Physical Activity and Community EmPOWERment ProjectUniversity of North Carolina, Chapel Hill
- RECRUITINGPHASE2NCT06081348Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental DisordersHolland Bloorview Kids Rehabilitation Hospital
- RECRUITINGNANCT06279858Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X SyndromeSpecila hospital for cerebral palsy and developmental neurology
- RECRUITINGNANCT06088589Speech-in-noise Perception in Autism and Fragile XChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNANCT06139172Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)Rush University Medical Center